[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Single Cell Analysis Market Size, Share, and Analysis, By Product (Consumable and Instruments), By Application (Cancer, Immunology, Neurology, Stem cell, Non-invasive prenatal diagnosis, and Others), By Cell Type (Human, Animal, and Microbial), and End Users (Academic & Research laboratories, Biotechnology & Pharmaceutical companies, Hospitals and Diagnostic laboratories, and Others), and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2023-2032

February 2024 | 438 pages | ID: S52D0E089132EN
Fatpos Global

US$ 5,150.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Single Cell Analysis Market Size, Share, and Analysis, By Product (Consumable and Instruments), By Application (Cancer, Immunology, Neurology, Stem cell, Non-invasive prenatal diagnosis, and Others), By Cell Type (Human, Animal, and Microbial), and End Users (Academic & Research laboratories, Biotechnology & Pharmaceutical companies, Hospitals and Diagnostic laboratories, and Others), and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2023-2032

PRODUCT OVERVIEW

Single Cell Analysis Market is expected t%li%grow at a CAGR of 15.9% in the forecast period (2023-2032), with the market size valued at USD 3.20 billion in 2021 and projected t%li%reach USD 16.2 billion by 2032, up from USD 3.7 billion in 2022.

Single-cell analysis is the study of cell interactions, genomes, transcriptomics, proteomics, and metabolomics at the single-cell level. Technology advances, expanding applications in cancer research, and higher government funding for cell-based research are the main drivers of growth in the single-cell analysis market. In addition, the market is advancing as a result of the epidemic. Single-cell RNA sequencing is used in cancer research t%li%examine complex tissues at the level of the individual cells, identifying differences in gene expression and tracking the growth of tumors t%li%stop further cellular degeneration.

MARKET HIGHLIGHTS

Single Cell Analysis Market is expected t%li%reach USD 16.2 billion, growing at a CAGR of 15.9% owing t%li%the advances in genomics, transcriptomics, and proteomics, which enable researchers t%li%examine biological complexity at the single-cell level. Applications in cancer research, immunology, and neuroscience are key drivers, fuelling demand for technologies such as single-cell RNA sequencing and flow cytometry. Furthermore, the industry benefits from the advancement of customized medicine and drug discovery initiatives.

Single Cell Analysis Market Segments:
  • By Product
  • Consumables
  • Instruments
  • By Application
  • Cancer
  • Immunology
  • Neurology
  • Stem cell
  • Non-invasive prenatal diagnosis
  • Others
  • By Cell Type
  • Human
  • Animal
  • Microbial
  • By End Users
  • Academic & Research laboratories
  • Biotechnology & Pharmaceutical companies
  • Hospitals and Diagnostic laboratories
  • Others
MARKET DYNAMICS

Growth Drivers

Increasing cancer prevalence t%li%drive market growth

Swift economic expansion t%li%boost market growth

Restraint

High cost of single-cell analysis products

Key Players
  • Illumina Inc.
  • 10x Genomics Inc.
  • Fluidigm Corporation
  • BD Biosciences
  • Mission Bio
  • NanoString Technologies
    • Therm%li%Fisher Scientific
  • Bio-Rad Laboratories
  • Qiagen
  • Agilent Technologies
  • Miltenyi Biotec
    • Dolomite Bi%li%(a part of Blacktrace Holdings)
  • Bio-Techne Corporation
  • Zeiss Group
  • Abcam plc
  • Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
Global Laboratory Temperature Control Units Market is further segmented by region into:
  • North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
  • Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
  • Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
  • Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
  • Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
Reasons t%li%Purchase this Report
  • Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
  • Provision of market value (USD Billion) data for each segment and sub-segment
      • Indicates the region and segment that is expected t%li%witness the fastest growth as well as t%li%dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
    • The current as well as the future market outlook of the industry with respect t%li%recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
    • Provides insight int%li%the market through Value Chain
    • Market dynamics scenario, along with growth opportunities of the market in the years t%li%come
  • 3-month post-sales analyst support.
1. EXECUTIVE SUMMARY

1.1.Regional Market Share
1.2. Business Trends
1.3.Single Cell Analysis Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot

2. RESEARCH METHODOLOGY

2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
  2.5.1. Paid Sources
  2.5.2.Public Sources
2.6.Market Size Estimation and Data Triangulation

3. MARKET CHARACTERISTICS

3.1. Market Definition
3.2.Single Cell Analysis Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data

4. SINGLE CELL ANALYSIS MARKET – INDUSTRY INSIGHTS

4.1.Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability

5. MACROECONOMIC INDICATORS

6. RECENT DEVELOPMENTS

7.MARKET DYNAMICS

7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends

8. RISK ANALYSIS

9. MARKET ANALYSIS

9.1. Porters Five Forces
9.2.PEST Analysis
  9.2.1. Political
  9.2.2.Economic
  9.2.3.Social
  9.2.4.Technological

10. SINGLE CELL ANALYSIS MARKET

10.1.Overview
10.2. Historical Analysis (2019-2021)
  10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast

11.SINGLE CELL ANALYSIS MARKET SIZE & FORECAST 2022A-2032F

11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
  11.3.1.By Product
    11.3.1.1.Consumables
      11.3.1.1.1. By Value (USD Million) 2022-2032F
      11.3.1.1.2.Market Share (%) 2022-2032F
      11.3.1.1.3.Y-o-Y Growth (%) 2022-2032F
    11.3.1.2. Instruments
      11.3.1.2.1.By Value (USD Million) 2022-2032F
      11.3.1.2.2. Market Share (%) 2022-2032F
      11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
  11.3.2. By Application
    11.3.2.1.Cancer
      11.3.2.1.1.By Value (USD Million) 2022-2032F
      11.3.2.1.2. Market Share (%) 2022-2032F
      11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
    11.3.2.2. Immunology
      11.3.2.2.1. By Value (USD Million) 2022-2032F
      11.3.2.2.2.Market Share (%) 2022-2032F
      11.3.2.2.3.Y-o-Y Growth (%) 2022-2032F
    11.3.2.3. Neurology
      11.3.2.3.1. By Value (USD Million) 2022-2032F
      11.3.2.3.2.Market Share (%) 2022-2032F
      11.3.2.3.3.Y-o-Y Growth (%) 2022-2032F
    11.3.2.4. Stem Cell
      11.3.2.4.1. By Value (USD Million) 2022-2032F
      11.3.2.4.2.Market Share (%) 2022-2032F
      11.3.2.4.3. Y-o-Y Growth (%) 2022-2032F
    11.3.2.5. Non-invasive prenatal diagnosis
      11.3.2.5.1. By Value (USD Million) 2022-2032F
      11.3.2.5.2.Market Share (%) 2022-2032F
      11.3.2.5.3.Y-o-Y Growth (%) 2022-2032F
    11.3.2.6. Others
      11.3.2.6.1. By Value (USD Million) 2022-2032F
      11.3.2.6.2.Market Share (%) 2022-2032F
      11.3.2.6.3.Y-o-Y Growth (%) 2022-2032F
  11.3.3. By End Users
    11.3.3.1Academic & Research laboratories
      11.3.3.1.1 By Value (USD Million) 2022-2032F
      11.3.3.1.2Market Share (%) 2022-2032F
      11.3.3.1.3Y-o-Y Growth (%) 2022-2032F
    11.3.3.2Biotechnology & Pharmaceutical companies
      11.3.3.2.1By Value (USD Million) 2022-2032F
      11.3.3.2.2 Market Share (%) 2022-2032F
      11.3.3.3.1Y-o-Y Growth (%) 2022-2032F
    11.3.3.3Hospitals and Diagnostic laboratories
      11.3.3.3.1By Value (USD Million) 2022-2032F
      11.3.4.1.2Market Share (%) 2022-2032F
      11.3.4.1.3Y-o-Y Growth (%) 2022-2032F
    11.3.3.4Others
      11.3.3.4.1By Value (USD Million) 2022-2032F
      11.3.3.4.2 Market Share (%) 2022-2032F
      11.3.3.4.3 Y-o-Y Growth (%) 2022-2032F
  11.3.4By Cell Type
    11.3.4.1 Human
      11.3.4.1.1 By Value (USD Million) 2022-2032F
      11.3.4.1.2Market Share (%) 2022-2032F
      11.3.4.1.3Y-o-Y Growth (%) 2022-2032F
    11.3.4.2Animal
      11.3.4.2.1By Value (USD Million) 2022-2032F
      11.3.4.2.2 Market Share (%) 2022-2032F
      11.3.4.2.3 Y-o-Y Growth (%) 2022-2032F
    11.3.4.3Microbial
      11.3.4.3.1By Value (USD Million) 2022-2032F
      11.3.4.3.2 Market Share (%) 2022-2032F
      11.3.4.3.3 Y-o-Y Growth (%) 2022-2032F

12. NORTH AMERICA SINGLE CELL ANALYSIS MARKET SIZE & FORECAST 2022A-2032F

12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
  12.3.1. By Product
  12.3.2.By Application
  12.3.3.By End Users
  12.3.4.By Cell Type
12.4. Country
  12.4.1. United States
  12.4.2.Canada

13. EUROPE SINGLE CELL ANALYSIS MARKET SIZE & FORECAST 2022A-2032F

13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
  13.3.1. By Product
  13.3.2.By Application
  13.3.3.By End Users
  13.3.4.By Cell Type
13.4. Country
  13.4.1.Germany
  13.4.2.United Kingdom
  13.4.3.France
  13.4.4. Italy
  13.4.5.Spain
  13.4.6.Russia
  13.4.7.Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)

14. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET SIZE & FORECAST 2022A-2032F

14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
  14.3.1. By Product
  14.3.2.By Application
  14.3.3.By End Users
  14.3.4. By Cell Type
14.4. Country
  14.4.1. India
  14.4.2.China
  14.4.3. South Korea
  14.4.4. Japan
  14.4.5. Rest of APAC

15. MIDDLE EAST AND AFRICA SINGLE CELL ANALYSIS MARKET SIZE & FORECAST 2022A-2032F

15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
  15.3.1. By Product
  15.3.2.By Application
  15.3.3.By End Users
  15.3.4.By Cell Type
15.4. Country
  15.4.1. Israel
  15.4.2.GCC
  15.4.3.North Africa
  15.4.4. South Africa
  15.4.5.Rest of Middle East and Africa

16. LATIN AMERICA SINGLE CELL ANALYSIS MARKET SIZE & FORECAST 2022A-2032F

16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
  16.3.1. By Product
  16.3.2.By Application
  16.3.3.By End Users
  16.3.4.By Cell Type
16.4. Country
  16.4.1. Mexico
  16.4.2.Brazil
  16.4.3.Rest of Latin America

17. COMPETITIVE LANDSCAPE

17.1. Company market share, 2021
17.2.Key player overview
17.3. Key stakeholders

18. COMPANY PROFILES

18.1.Illumina Inc.
  18.1.1.Company Overview
  18.1.2.Financial Overview
  18.1.3.Key Product; Analysis
  18.1.4.Company Assessment
    18.1.4.1.Product Portfolio
    18.1.4.2. Key Clients
    18.1.4.3. Market Share
    18.1.4.4. Recent News & Development (Last 3 Yrs.)
    18.1.4.5. Executive Team
18.2. 10x Genomics Inc.
18.3. Fluidigm Corporation
18.4.BD Biosciences
18.5.Mission Bio
18.6.NanoString Technologies
18.7.Thermo Fisher Scientific
18.8.Bio-Rad Laboratories
18.9.Qiagen
18.10.Agilent Technologies
18.11. Miltenyi Biotec
18.12.Dolomite Bio
18.13.Bio-Techne Corporation
18.14.Zeiss Group
18.15.Abcam plc
18.16.Other Prominent Players

19. APPENDIX

20.CONSULTANT RECOMMENDATION



More Publications